BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15505770)

  • 1. Immune-mediated inner ear disease: 10-year experience.
    Broughton SS; Meyerhoff WE; Cohen SB
    Semin Arthritis Rheum; 2004 Oct; 34(2):544-8. PubMed ID: 15505770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune inner ear disease.
    Ruckenstein MJ
    Curr Opin Otolaryngol Head Neck Surg; 2004 Oct; 12(5):426-30. PubMed ID: 15377956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.
    Harris JP; Weisman MH; Derebery JM; Espeland MA; Gantz BJ; Gulya AJ; Hammerschlag PE; Hannley M; Hughes GB; Moscicki R; Nelson RA; Niparko JK; Rauch SD; Telian SA; Brookhouser PE
    JAMA; 2003 Oct; 290(14):1875-83. PubMed ID: 14532316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demystifying autoimmune inner ear disease.
    Das S; Bakshi SS; Seepana R
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3267-3274. PubMed ID: 31605190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-mediated inner ear disease and parvovirus B19.
    Cotter CS; Singleton GT; Corman LC
    Laryngoscope; 1994 Oct; 104(10):1235-9. PubMed ID: 7934594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune inner ear disease: steroid and cytotoxic drug therapy.
    Lasak JM; Sataloff RT; Hawkshaw M; Carey TE; Lyons KM; Spiegel JR
    Ear Nose Throat J; 2001 Nov; 80(11):808-11, 815-6, 818 passim. PubMed ID: 11816893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapsing autoimmune inner ear disease with significant response to methotrexate and azathioprine combination therapy: A case report and mini literature review.
    Huang KH; Lin HC; Lin CD; Wu PC
    Medicine (Baltimore); 2023 Jun; 102(23):e33889. PubMed ID: 37335659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive therapy for autoimmune inner ear disease.
    Buniel MC; Geelan-Hansen K; Weber PC; Tuohy VK
    Immunotherapy; 2009 May; 1(3):425-34. PubMed ID: 19885385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cochlin in autoimmune inner ear disease: is the search for an inner ear autoantigen over?
    Baruah P
    Auris Nasus Larynx; 2014 Dec; 41(6):499-501. PubMed ID: 25199741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study.
    Cohen S; Shoup A; Weisman MH; Harris J
    Otol Neurotol; 2005 Sep; 26(5):903-7. PubMed ID: 16151336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-mediated inner ear disorders.
    Moscicki RA
    Baillieres Clin Neurol; 1994 Nov; 3(3):547-63. PubMed ID: 7874408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept, a tumour necrosis factor alpha receptor antagonist, and methotrexate in acute sensorineural hearing loss.
    Street I; Jobanputra P; Proops DW
    J Laryngol Otol; 2006 Dec; 120(12):1064-6. PubMed ID: 17040588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune inner ear disease (AIED): A diagnostic challenge.
    Ciorba A; Corazzi V; Bianchini C; Aimoni C; Pelucchi S; Skarżyński PH; Hatzopoulos S
    Int J Immunopathol Pharmacol; 2018; 32():2058738418808680. PubMed ID: 30376736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternatives to systemic steroid therapy for refractory immune-mediated inner ear disease: A physiopathologic approach.
    García-Berrocal JR; Ibáñez A; Rodríguez A; González-García JA; Verdaguer JM; Trinidad A; Ramírez-Camacho R
    Eur Arch Otorhinolaryngol; 2006 Nov; 263(11):977-82. PubMed ID: 16802138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune inner ear disease: diagnostic and therapeutic approaches in a multidisciplinary setting.
    Matteson EL; Fabry DA; Strome SE; Driscoll CL; Beatty CW; McDonald TJ
    J Am Acad Audiol; 2003; 14(4):225-30. PubMed ID: 12940706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid response and supporting cell antibody in autoimmune hearing loss.
    Zeitoun H; Beckman JG; Arts HA; Lansford CD; Lee DS; El-Kashlan HK; Telian SA; Denny DE; Ramakrishnan A; Nair TS; Disher MJ; Sataloff RT; Fisher SG; Carey TE
    Arch Otolaryngol Head Neck Surg; 2005 Aug; 131(8):665-72. PubMed ID: 16103296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-mediated sensorineural hearing loss.
    Veldman J
    Auris Nasus Larynx; 1998 Sep; 25(3):309-17. PubMed ID: 9799999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric fluctuating sensorineural hearing loss: problems in medical management.
    Dinces EA; Yang S; Balogun AO
    Laryngoscope; 2001 Jan; 111(1):21-5. PubMed ID: 11192894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinician Faced With Anticochlear Antibodies: What to Do With Them?
    Carlomagno A; Silveira G; Rebella M; Vola M; Danza A
    J Clin Rheumatol; 2018 Apr; 24(3):113-115. PubMed ID: 29116948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric Autoimmune Inner Ear Disease: A Rare, But Treatable Condition.
    Oz RS; Gluth M; Tesher MS
    Pediatr Ann; 2019 Oct; 48(10):e391-e394. PubMed ID: 31609997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.